It makes it very clear in the 10-K that $2M were spent in admin fees. most of that goes into paying salaries and Baruch gets a large portion. Moreover, research and development expenses of $141,858 a year on actual science will not get anything done. That is toy money that the sub-dime companies pay for their stuff. Real work costs much more than that. If OWCP does not multiply their research and development expenses by 10 and cut some bogus administrative salaries, this stock is going to go under a dime real fast. This is obviously the most overrated OTC stock there is. If the fat salaries were cut, dilution would not be necessary.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Be advised that if someone attacks me, that post is not removed, but my response will always be removed. These mods are not unbiased, especially 1, so I have to be extra careful.
Here is what happens when the mods are against me: if I make even 1 mistake, the admins will uphold the deletion by the mods, but if someone attacks me, violating pretty much every rule, then a simple mod refusal to delete is enough and the admins do not get involved.
Also, I am the only person who does not get enraged at others' posts, mostly because I am unbiased. I am in search of the truth. Those who abuse the most have huge stakes in the company and therefore want to silence those who disagree with them